# Evaluation of an Absorbable Surgical Hemostatic Agent: Thrombi-Gel® Versus Gelfoam-Thrombin

> **NCT00652314** · PHASE4 · COMPLETED · sponsor: **Vascular Solutions LLC** · enrollment: 97 (actual)

## Conditions studied

- Operation Site Bleed

## Interventions

- **DEVICE:** Thrombi-Gel

## Key facts

- **NCT ID:** NCT00652314
- **Lead sponsor:** Vascular Solutions LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-10
- **Final completion:** 2010-01
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2016-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00652314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00652314, "Evaluation of an Absorbable Surgical Hemostatic Agent: Thrombi-Gel® Versus Gelfoam-Thrombin". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00652314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*